AbbVie CDR (CAD Hedged) (ABBV) Income Statement & Earnings

30.550
-0.710-2.27%

15min DelayMarket Closed Jan 15 16:00 ET

510.18BMarket Cap157.47P/E (TTM)

AbbVie CDR (CAD Hedged) (ABBV) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

Total revenue

9.10%15.78B

6.65%15.42B

8.39%13.34B

3.71%56.33B

5.60%15.1B

3.83%14.46B

4.31%14.46B

0.70%12.31B

-6.44%54.32B

-5.42%14.3B

Operating revenue

9.10%15.78B

6.65%15.42B

8.39%13.34B

3.71%56.33B

5.60%15.1B

3.83%14.46B

4.31%14.46B

0.70%12.31B

-6.44%54.32B

-5.42%14.3B

Cost of revenue

25.93%5.3B

3.43%4.35B

-2.25%4B

-17.20%16.9B

-22.93%4.4B

-35.05%4.21B

-0.90%4.2B

2.71%4.09B

17.23%20.42B

36.79%5.7B

Gross profit

2.19%10.47B

7.96%11.08B

13.69%9.34B

16.30%39.43B

24.53%10.71B

37.70%10.25B

6.60%10.26B

-0.28%8.22B

-16.58%33.9B

-21.50%8.6B

Operating expense

-7.06%5.89B

0.66%5.36B

2.02%5.36B

35.19%27.54B

107.46%10.62B

24.34%6.34B

10.20%5.33B

-1.26%5.25B

-6.68%20.37B

7.74%5.12B

Selling and administrative expenses

-15.12%3.57B

-3.67%3.25B

-0.66%3.29B

14.61%14.75B

20.73%3.86B

24.70%4.21B

3.34%3.38B

9.08%3.32B

-15.65%12.87B

-6.56%3.19B

Research and development costs

8.87%2.32B

9.39%2.13B

6.60%2.07B

66.66%12.79B

251.53%6.77B

23.62%2.13B

12.41%1.95B

-15.40%1.94B

17.90%7.68B

44.24%1.93B

Other operating expenses

----

---24M

----

96.09%-7M

----

-419.64%-179M

--0

Operating profit

17.15%4.58B

15.85%5.72B

34.40%3.98B

-12.12%11.89B

-97.58%84M

66.72%3.91B

2.96%4.94B

1.51%2.96B

-28.06%13.54B

-43.91%3.48B

Net non-operating interest income (expenses)

-12.86%-667M

-33.99%-678M

-38.41%-627M

-28.27%-2.16B

-61.38%-610M

-48.49%-591M

-11.45%-506M

0.22%-453M

17.61%-1.68B

20.59%-378M

Non-operating interest income

-44.19%72M

-71.82%62M

-64.73%73M

20.00%648M

-50.54%92M

-17.83%129M

124.49%220M

109.09%207M

190.32%540M

106.67%186M

Non-operating interest expense

2.64%739M

1.93%740M

6.06%700M

26.26%2.81B

24.47%702M

29.73%720M

31.52%726M

19.35%660M

-0.27%2.22B

-0.35%564M

Other net income (expenses)

-158.72%-3.2B

-52.65%-3.49B

-124.54%-1.69B

-7.45%-6.02B

7.63%-1.74B

-31,050.00%-1.24B

-32.04%-2.28B

62.09%-754M

-70.09%-5.6B

31.58%-1.89B

Gain on sale of security

-766.67%-20M

-2,200.00%-23M

0.00%-4M

85.62%-21M

61.22%-19M

112.00%3M

97.30%-1M

88.57%-4M

1.35%-146M

-22.50%-49M

Special income (charges)

-3,168.29%-2.68B

12.17%-823M

-51.22%-248M

-254.37%-2.76B

-458.16%-1.57B

-24.24%-82M

-234.64%-937M

-9.33%-164M

-11.62%-778M

---282M

-Less:Other special charges

3,168.29%2.68B

-12.17%823M

51.22%248M

254.37%2.76B

458.16%1.57B

24.24%82M

234.64%937M

9.33%164M

11.62%778M

--282M

Other non-operating income (expenses)

56.60%-503M

-96.21%-2.64B

-145.90%-1.44B

30.72%-3.24B

90.36%-150M

-1,320.00%-1.16B

4.75%-1.35B

67.52%-586M

-91.05%-4.68B

23.01%-1.56B

Income before tax

-65.74%714M

-27.59%1.55B

-5.36%1.66B

-40.54%3.72B

-287.21%-2.27B

6.71%2.08B

-17.78%2.15B

269.47%1.76B

-53.62%6.25B

-59.12%1.21B

Income tax

1.15%526M

-20.70%613M

-2.87%372M

-141.39%-570M

-678.87%-2.25B

202.33%520M

32.59%773M

63.68%383M

-15.63%1.38B

-21.30%388M

Earnings from equity interest net of tax

Net income

-87.98%188M

-31.46%941M

-6.05%1.29B

-12.05%4.29B

-102.79%-23M

-12.18%1.56B

-32.26%1.37B

469.29%1.37B

-58.86%4.87B

-66.67%824M

Net income continuous operations

-87.98%188M

-31.46%941M

-6.05%1.29B

-12.05%4.29B

-102.79%-23M

-12.18%1.56B

-32.26%1.37B

469.29%1.37B

-58.86%4.87B

-66.67%824M

Noncontrolling interests

-33.33%2M

0.00%3M

-20.00%8M

-150.00%-1M

0.00%3M

50.00%3M

11.11%10M

300.00%2M

Net income attributable to the company

-88.08%186M

-31.53%938M

-6.06%1.29B

-12.03%4.28B

-102.68%-22M

-12.20%1.56B

-32.31%1.37B

472.80%1.37B

-58.91%4.86B

-66.76%822M

Preferred stock dividends

Other under preferred stock dividend

0.00%10M

-6.98%40M

-9.09%10M

-20.37%43M

11M

Net income attributable to common stockholders

-88.65%176M

-31.76%928M

-6.11%1.28B

-12.07%4.24B

-103.95%-32M

-12.22%1.55B

-32.44%1.36B

496.05%1.36B

-59.09%4.82B

-66.47%811M

Diluted earnings per share

-88.64%0.0106

-32.47%0.055

-6.49%0.0762

-12.09%0.254

-102.68%-0.0013

-12.00%0.0931

-32.46%0.0815

492.32%0.0815

-58.95%0.2889

-66.70%0.0493

Basic earnings per share

-88.64%0.0106

-32.47%0.055

-6.49%0.0762

-12.13%0.2529

-104.35%-0.0021

-12.00%0.0931

-32.46%0.0815

492.32%0.0815

-58.97%0.2879

-66.67%0.0487

Dividend per share

4.01%0.1697

3.94%0.1707

-4.88%0.1617

2.16%0.6611

3.49%0.1637

-2.57%0.1632

2.71%0.1642

5.21%0.1701

0.6471

0.1582

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023
Total revenue	9.10%15.78B	6.65%15.42B	8.39%13.34B	3.71%56.33B	5.60%15.1B	3.83%14.46B	4.31%14.46B	0.70%12.31B	-6.44%54.32B	-5.42%14.3B
Operating revenue	9.10%15.78B	6.65%15.42B	8.39%13.34B	3.71%56.33B	5.60%15.1B	3.83%14.46B	4.31%14.46B	0.70%12.31B	-6.44%54.32B	-5.42%14.3B
Cost of revenue	25.93%5.3B	3.43%4.35B	-2.25%4B	-17.20%16.9B	-22.93%4.4B	-35.05%4.21B	-0.90%4.2B	2.71%4.09B	17.23%20.42B	36.79%5.7B
Gross profit	2.19%10.47B	7.96%11.08B	13.69%9.34B	16.30%39.43B	24.53%10.71B	37.70%10.25B	6.60%10.26B	-0.28%8.22B	-16.58%33.9B	-21.50%8.6B
Operating expense	-7.06%5.89B	0.66%5.36B	2.02%5.36B	35.19%27.54B	107.46%10.62B	24.34%6.34B	10.20%5.33B	-1.26%5.25B	-6.68%20.37B	7.74%5.12B
Selling and administrative expenses	-15.12%3.57B	-3.67%3.25B	-0.66%3.29B	14.61%14.75B	20.73%3.86B	24.70%4.21B	3.34%3.38B	9.08%3.32B	-15.65%12.87B	-6.56%3.19B
Research and development costs	8.87%2.32B	9.39%2.13B	6.60%2.07B	66.66%12.79B	251.53%6.77B	23.62%2.13B	12.41%1.95B	-15.40%1.94B	17.90%7.68B	44.24%1.93B
Other operating expenses	----	---24M	----	96.09%-7M	----	----	----	----	-419.64%-179M	--0
Operating profit	17.15%4.58B	15.85%5.72B	34.40%3.98B	-12.12%11.89B	-97.58%84M	66.72%3.91B	2.96%4.94B	1.51%2.96B	-28.06%13.54B	-43.91%3.48B
Net non-operating interest income (expenses)	-12.86%-667M	-33.99%-678M	-38.41%-627M	-28.27%-2.16B	-61.38%-610M	-48.49%-591M	-11.45%-506M	0.22%-453M	17.61%-1.68B	20.59%-378M
Non-operating interest income	-44.19%72M	-71.82%62M	-64.73%73M	20.00%648M	-50.54%92M	-17.83%129M	124.49%220M	109.09%207M	190.32%540M	106.67%186M
Non-operating interest expense	2.64%739M	1.93%740M	6.06%700M	26.26%2.81B	24.47%702M	29.73%720M	31.52%726M	19.35%660M	-0.27%2.22B	-0.35%564M
Other net income (expenses)	-158.72%-3.2B	-52.65%-3.49B	-124.54%-1.69B	-7.45%-6.02B	7.63%-1.74B	-31,050.00%-1.24B	-32.04%-2.28B	62.09%-754M	-70.09%-5.6B	31.58%-1.89B
Gain on sale of security	-766.67%-20M	-2,200.00%-23M	0.00%-4M	85.62%-21M	61.22%-19M	112.00%3M	97.30%-1M	88.57%-4M	1.35%-146M	-22.50%-49M
Special income (charges)	-3,168.29%-2.68B	12.17%-823M	-51.22%-248M	-254.37%-2.76B	-458.16%-1.57B	-24.24%-82M	-234.64%-937M	-9.33%-164M	-11.62%-778M	---282M
-Less:Other special charges	3,168.29%2.68B	-12.17%823M	51.22%248M	254.37%2.76B	458.16%1.57B	24.24%82M	234.64%937M	9.33%164M	11.62%778M	--282M
Other non-operating income (expenses)	56.60%-503M	-96.21%-2.64B	-145.90%-1.44B	30.72%-3.24B	90.36%-150M	-1,320.00%-1.16B	4.75%-1.35B	67.52%-586M	-91.05%-4.68B	23.01%-1.56B
Income before tax	-65.74%714M	-27.59%1.55B	-5.36%1.66B	-40.54%3.72B	-287.21%-2.27B	6.71%2.08B	-17.78%2.15B	269.47%1.76B	-53.62%6.25B	-59.12%1.21B
Income tax	1.15%526M	-20.70%613M	-2.87%372M	-141.39%-570M	-678.87%-2.25B	202.33%520M	32.59%773M	63.68%383M	-15.63%1.38B	-21.30%388M
Earnings from equity interest net of tax
Net income	-87.98%188M	-31.46%941M	-6.05%1.29B	-12.05%4.29B	-102.79%-23M	-12.18%1.56B	-32.26%1.37B	469.29%1.37B	-58.86%4.87B	-66.67%824M
Net income continuous operations	-87.98%188M	-31.46%941M	-6.05%1.29B	-12.05%4.29B	-102.79%-23M	-12.18%1.56B	-32.26%1.37B	469.29%1.37B	-58.86%4.87B	-66.67%824M
Noncontrolling interests	-33.33%2M	0.00%3M	0.00%3M	-20.00%8M	-150.00%-1M	0.00%3M	0.00%3M	50.00%3M	11.11%10M	300.00%2M
Net income attributable to the company	-88.08%186M	-31.53%938M	-6.06%1.29B	-12.03%4.28B	-102.68%-22M	-12.20%1.56B	-32.31%1.37B	472.80%1.37B	-58.91%4.86B	-66.76%822M
Preferred stock dividends
Other under preferred stock dividend	0.00%10M	0.00%10M	0.00%10M	-6.98%40M	-9.09%10M	-9.09%10M	-9.09%10M	-9.09%10M	-20.37%43M	11M
Net income attributable to common stockholders	-88.65%176M	-31.76%928M	-6.11%1.28B	-12.07%4.24B	-103.95%-32M	-12.22%1.55B	-32.44%1.36B	496.05%1.36B	-59.09%4.82B	-66.47%811M
Diluted earnings per share	-88.64%0.0106	-32.47%0.055	-6.49%0.0762	-12.09%0.254	-102.68%-0.0013	-12.00%0.0931	-32.46%0.0815	492.32%0.0815	-58.95%0.2889	-66.70%0.0493
Basic earnings per share	-88.64%0.0106	-32.47%0.055	-6.49%0.0762	-12.13%0.2529	-104.35%-0.0021	-12.00%0.0931	-32.46%0.0815	492.32%0.0815	-58.97%0.2879	-66.67%0.0487
Dividend per share	4.01%0.1697	3.94%0.1707	-4.88%0.1617	2.16%0.6611	3.49%0.1637	-2.57%0.1632	2.71%0.1642	5.21%0.1701	0.6471	0.1582
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"